GC65010
Bortezomib-d8
Bortezomib-d8 (PS-341-d8) is the deuterium labeled Bortezomib· Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0·6 nM) by targeting a threonine residue· Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB· Bortezomib is the first proteasome inhibitor anticancer agent· Anti-cancer activity
ChemicalMW392.29FormulaC19H17D8BN4O4
- CAS number
- —
- Molecular weight
- 392.29
- Formula
- C19H17D8BN4O4
- Catalogue number
- GC65010
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il